CLINICAL_TRIALS
trial_result
· 2016-02-25
Clinical Trial Update: CC-4047 (Pomalidomide) for Graft vs. Host Disease [Phase 2]
Summary
Phase 2 trial of pomalidomide (CC-4047) for graft-versus-host disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-02-25